The capsid protein of human immunodeficiency virus: Interactions of HIV-1 capsid with host protein factors

FEBS Journal

Volumn 276, Issue 21, 2009, Pages 6118-6127

  Mascarenhas, Anjali P ^a   Musier Forsyth, Karin ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cyclophilin A; Cyclophilins; Gag; HIV 1 capsid; Lysyl tRNA synthetase; TRIM proteins; TRIM ; TRNA primer packaging; Viral assembly

Indexed keywords

CYCLOPHILIN A; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LYSINE TRANSFER RNA LIGASE; NUCLEOCAPSID PROTEIN; PRIMER RNA; TRIPARTITE MOTIF PROTEIN 5;

ANISOTROPY; DIMERIZATION; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS INHIBITION;

CAPSID PROTEINS; CARRIER PROTEINS; CYCLOPHILIN A; HIV-1; HUMANS; LYSINE-TRNA LIGASE; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 70349947190     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07315.x     Document Type: Short Survey

References (80)

1. Park J Morrow CD (1992) The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into virus like particles. J Virol 66, 6304 6313.
2. Smith AJ, Cho MI, Hammarskjold ML Rekosh D (1990) Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into virus like particles. J Virol 64, 2743 2750.
3. Smith AJ, Srinivasakumar N, Hammarskjold ML Rekosh D (1993) Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J Virol 67, 2266 2275.
4. Srinivasakumar N, Hammarskjold ML Rekosh D (1995) Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol 69, 6106 6114.
5. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J Elledge SJ (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921 926.
6. Isel C, Lanchy JM, Le Grice SF, Ehresmann C, Ehresmann B Marquet R (1996) Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys. EMBO J 15, 917 924.
7. Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B Kleiman L (1993) Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 67, 3246 3253.
8. Harada F, Peters GG Dahlberg JE (1979) The primer tRNA for Moloney murine leukemia virus DNA synthesis. Nucleotide sequence and aminoacylation of tRNAPro. J Biol Chem 254, 10979 10985.
9. Cen S, Khorchid A, Javanbakht H, Gabor J, Stello T, Shiba K, Musier-Forsyth K Kleiman L (2001) Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J Virol 75, 5043 5048.
10. Halwani R, Cen S, Javanbakht H, Saadatmand J, Kim S, Shiba K Kleiman L (2004) Cellular distribution of lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly. J Virol 78, 7553 7564.
11. Lys3 aminoacylation and its incorporation into HIV-1. J Biol Chem 277, 17389 17396.
12. Cen S, Javanbakht H, Niu M Kleiman L (2004) Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1. J Virol 78, 1595 1601.
13. Gabor J, Cen S, Javanbakht H, Niu M Kleiman L (2002) Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity. J Virol 76, 9096 9102.
14. Cen S, Javanbakht H, Kim S, Shiba K, Craven R, Rein A, Ewalt K, Schimmel P, Musier-Forsyth K Kleiman L (2002) Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs. J Virol 76, 13111 13115.
15. Guo F, Cen S, Niu M, Javanbakht H Kleiman L (2003) Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1. J Virol 77, 9817 9822.
16. Guo M, Ignatov M, Musier-Forsyth K, Schimmel P Yang XL (2008) Crystal structure of tetrameric form of human lysyl-tRNA synthetase: implications for multisynthetase complex formation. Proc Natl Acad Sci USA 105, 2331 2336.
17. Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H Kleiman L (2003) The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J Biol Chem 278, 27644 27651.
18. Kovaleski BJ, Kennedy R, Hong MK, Datta SA, Kleiman L, Rein A Musier-Forsyth K (2006) In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase. J Biol Chem 281, 19449 19456.
19. Ivanov D, Stone JR, Maki JL, Collins T Wagner G (2005) Mammalian SCAN domain dimer is a domain-swapped homolog of the HIV capsid C-terminal domain. Mol Cell 17, 137 143.
20. Worthylake DK, Wang H, Yoo S, Sundquist WI Hill CP (1999) Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallogr D Biol Crystallogr 55, 85 92.
21. Wills JW Craven RC (1991) Form, function, and use of retroviral gag proteins. AIDS 5, 639 654.
22. von Schwedler UK, Stray KM, Garrus JE Sundquist WI (2003) Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 77, 5439 5450.
23. Kovaleski BJ, Kennedy R, Khorchid A, Kleiman L, Matsuo H Musier-Forsyth K (2007) Critical role of helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase. J Biol Chem 282, 32274 32279.
24. Fruman DA, Burakoff SJ Bierer BE (1994) Immunophilins in protein folding and immunosuppression. FASEB J 8, 391 400.
25. Stamnes MA, Rutherford SL Zuker CS (1992) Cyclophilins: a new family of proteins involved in intracellular folding. Trends Cell Biol 2, 272 276.
26. Trandinh CC, Pao GM, Saier MH Jr. (1992) Structural and evolutionary relationships among the immunophilins: two ubiquitous families of peptidyl-prolyl cis-trans isomerases. FASEB J 6, 3410 3420.
27. Matouschek A, Rospert S, Schmid K, Glick BS Schatz G (1995) Cyclophilin catalyzes protein folding in yeast mitochondria. Proc Natl Acad Sci USA 92, 6319 6323.
28. Lodish HF Kong N (1991) Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. J Biol Chem 266, 14835 14838.
29. Steinmann B, Bruckner P Superti-Furga A (1991) Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J Biol Chem 266, 1299 1303.
30. Franke EK, Yuan HE Luban J (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359 362.
31. Luban J, Bossolt KL, Franke EK, Kalpana GV Goff SP (1993) Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067 1078.
32. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J Gottlinger HG (1994) Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363 365.
33. Braaten D, Franke EK Luban J (1996) Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol 70, 3551 3560.
34. Luban J (1996) Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell 87, 1157 1159.
35. Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E et al. (1995) Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. J Virol 69, 814 824.
36. Kallen J Walkinshaw MD (1992) The X-ray structure of a tetrapeptide bound to the active site of human cyclophilin A. FEBS Lett 300, 286 290.
37. Ke HM, Zydowsky LD, Liu J Walsh CT (1991) Crystal structure of recombinant human T-cell cyclophilin A at 2.5 Å resolution. Proc Natl Acad Sci USA 88, 9483 9487.
38. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI Hill CP (1996) Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285 1294. (Pubitemid 27010111)
39. Vajdos FF, Yoo S, Houseweart M, Sundquist WI Hill CP (1997) Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci 6, 2297 2307.
40. Yoo S, Myszka DG, Yeh C, McMurray M, Hill CP Sundquist WI (1997) Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol Biol 269, 780 795.
41. Endrich MM, Gehrig P Gehring H (1999) Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain. J Biol Chem 274, 5326 5332.
42. Bosco DA, Eisenmesser EZ, Pochapsky S, Sundquist WI Kern D (2002) Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc Natl Acad Sci USA 99, 5247 5252.
43. Zhao Y, Chen Y, Schutkowski M, Fischer G Ke H (1997) Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 5, 139 146.
44. Howard BR, Vajdos FF, Li S, Sundquist WI Hill CP (2003) Structural insights into the catalytic mechanism of cyclophilin A. Nat Struct Biol 10, 475 481.
45. Bristow R, Byrne J, Squirell J, Trencher H, Carter T, Rodgers B, Saman E Duncan J (1999) Human cyclophilin has a significantly higher affinity for HIV-1 recombinant p55 than p24. J Acquir Immune Defic Syndr Hum Retrovirol 20, 334 336.
46. Dietrich L, Ehrlich LS, LaGrassa TJ, Ebbets-Reed D Carter C (2001) Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. J Virol 75, 4721 4733.
47. Colgan J, Yuan HE, Franke EK Luban J (1996) Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J Virol 70, 4299 4310.
48. Agresta BE Carter CA (1997) Cyclophilin A-induced alterations of human immunodeficiency virus type 1 CA protein in vitro. J Virol 71, 6921 6927.
49. Luban J (2007) Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol 81, 1054 1061.
50. Saphire AC, Bobardt MD Gallay PA (2000) Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells. Immunol Res 21, 211 217.
51. Takeuchi H Matano T (2008) Host factors involved in resistance to retroviral infection. Microbiol Immunol 52, 318 325.
52. Towers GJ (2007) The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 4, 40.
53. Liu S, Asparuhova M, Brondani V, Ziekau I, Klimkait T Schumperli D (2004) Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res 32, 3752 3759.
54. Li J, Tan Z, Tang S, Hewlett I, Pang R, He M, He S, Tian B, Chen K Yang M (2009) Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid. Bioorg Med Chem 17, 3177 3188.
55. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD Towers GJ (2003) Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 22, 385 394.
56. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P Sodroski J (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848 853.
57. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S Bieniasz PD (2004) Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc Natl Acad Sci USA 101, 10774 10779.
58. Yap MW, Nisole S, Lynch C Stoye JP (2004) Trim5α protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA 101, 10786 10791.
59. Keckesova Z, Ylinen LM Towers GJ (2004) The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci USA 101, 10780 10785.
60. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S et al. (2001) The tripartite motif family identifies cell compartments. EMBO J 20, 2140 2151.
61. Perez-Caballero D, Hatziioannou T, Yang A, Cowan S Bieniasz PD (2005) Human tripartite motif 5α domains responsible for retrovirus restriction activity and specificity. J Virol 79, 8969 8978.
62. Sawyer SL, Wu LI, Emerman M Malik HS (2005) Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci USA 102, 2832 2837.
63. Yap MW, Nisole S Stoye JP (2005) A single amino acid change in the SPRY domain of human Trim5α leads to HIV-1 restriction. Curr Biol 15, 73 78.
64. Stremlau M, Perron M, Welikala S Sodroski J (2005) Species-specific variation in the B30.2(SPRY) domain of TRIM5α determines the potency of human immunodeficiency virus restriction. J Virol 79, 3139 3145.
65. Sebastian S, Grutter C, de Castillia CS, Pertel T, Olivari S, Grutter MG Luban J (2009) An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding. J Virol 83, 3365 3373.
66. Grutter C, Briand C, Capitani G, Mittl PR, Papin S, Tschopp J Grutter MG (2006) Structure of the PRYSPRY-domain: implications for autoinflammatory diseases. FEBS Lett 580, 99 106.
67. James LC, Keeble AH, Khan Z, Rhodes DA Trowsdale J (2007) Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci USA 104, 6200 6205.
68. Woo JS, Imm JH, Min CK, Kim KJ, Cha SS Oh BH (2006) Structural and functional insights into the B30.2/SPRY domain. EMBO J 25, 1353 1363.
69. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI Sodroski J (2006) Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 103, 5514 5519.
70. Forshey BM, von Schwedler U, Sundquist WI Aiken C (2002) Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76, 5667 5677.
71. Ganser BK, Li S, Klishko VY, Finch JT Sundquist WI (1999) Assembly and analysis of conical models for the HIV-1 core. Science 283, 80 83.
72. Mische CC, Javanbakht H, Song B, Diaz-Griffero F, Stremlau M, Strack B, Si Z Sodroski J (2005) Retroviral restriction factor TRIM5α is a trimer. J Virol 79, 14446 14450.
73. Rold CJ Aiken C (2008) Proteasomal degradation of TRIM5α during retrovirus restriction. PLoS Pathog 4, e1000074.
74. Sakuma R, Noser JA, Ohmine S Ikeda Y (2007) Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nat Med 13, 631 635.
75. Sayah DM, Sokolskaja E, Berthoux L Luban J (2004) Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569 573.
76. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J Bieniasz PD (2003) Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 9, 1138 1143.
77. Nisole S, Lynch C, Stoye JP Yap MW (2004) A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci USA 101, 13324 13328.
78. Greene WC, Debyser Z, Ikeda Y, Freed EO, Stephens E, Yonemoto W, Buckheit RW, Este JA Cihlar T (2008) Novel targets for HIV therapy. Antiviral Res 80, 251 265.
79. Berthet-Colominas C, Monaco S, Novelli A, Sibai G, Mallet F Cusack S (1999) Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J 18, 1124 1136.
80. Song B, Gold B, O'Huigin C, Javanbakht H, Li X, Stremlau M, Winkler C, Dean M Sodroski J (2005) The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J Virol 79, 6111 6121.